Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Amazon Spends $2.75bn on AI Startup Anthropic in its Largest Venture Investment
Amazon is spending billions more to back an artificial intelligence startup as it looks for an edge in the new technology arms race. It would spend another $2.75 billion backing Anthropic, adding to its initial $1.25 billion check. Amazon is making its largest...
Blackstone to invest US$25bn in India PE assets over five years
BLACKSTONE plans to assemble a US$25 billion portfolio of Indian private equity assets over the next five years, reflecting the South Asian country’s increasing allure to global investors. The New York-based firm also intends to add 20 investment professionals to its...
Mubadala Investment Company Acquires 100% of KELIX Bio in Full Ownership Deal
Mubadala supporting UAE’s vision to become a global leader in the life sciences sector. The acquisition of KELIX bio will reinforce the UAE’s biopharma ecosystem and increase Mubadala’s presence regionally and globally. The sold stake represents the full ownership of...